JP2019524131A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2019524131A5 JP2019524131A5 JP2019507161A JP2019507161A JP2019524131A5 JP 2019524131 A5 JP2019524131 A5 JP 2019524131A5 JP 2019507161 A JP2019507161 A JP 2019507161A JP 2019507161 A JP2019507161 A JP 2019507161A JP 2019524131 A5 JP2019524131 A5 JP 2019524131A5
- Authority
- JP
- Japan
- Prior art keywords
- strain
- poxvirus
- nucleic acid
- vaccinia virus
- chimeric
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Priority Applications (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2022017693A JP7395628B2 (ja) | 2016-08-09 | 2022-02-08 | キメラポックスウイルス組成物及びその使用 |
| JP2023200433A JP7631485B2 (ja) | 2016-08-09 | 2023-11-28 | キメラポックスウイルス組成物及びその使用 |
| JP2025016649A JP2025072482A (ja) | 2016-08-09 | 2025-02-04 | キメラポックスウイルス組成物及びその使用 |
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201662372408P | 2016-08-09 | 2016-08-09 | |
| US62/372,408 | 2016-08-09 | ||
| US201762519010P | 2017-06-13 | 2017-06-13 | |
| US62/519,010 | 2017-06-13 | ||
| PCT/US2017/046163 WO2018031694A1 (en) | 2016-08-09 | 2017-08-09 | Chimeric poxvirus compositions and uses thereof |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017693A Division JP7395628B2 (ja) | 2016-08-09 | 2022-02-08 | キメラポックスウイルス組成物及びその使用 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2019524131A JP2019524131A (ja) | 2019-09-05 |
| JP2019524131A5 true JP2019524131A5 (https=) | 2020-09-17 |
| JP7023929B2 JP7023929B2 (ja) | 2022-02-22 |
Family
ID=61163330
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2019507161A Active JP7023929B2 (ja) | 2016-08-09 | 2017-08-09 | キメラポックスウイルス組成物及びその使用 |
| JP2022017693A Active JP7395628B2 (ja) | 2016-08-09 | 2022-02-08 | キメラポックスウイルス組成物及びその使用 |
| JP2023200433A Active JP7631485B2 (ja) | 2016-08-09 | 2023-11-28 | キメラポックスウイルス組成物及びその使用 |
| JP2025016649A Pending JP2025072482A (ja) | 2016-08-09 | 2025-02-04 | キメラポックスウイルス組成物及びその使用 |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022017693A Active JP7395628B2 (ja) | 2016-08-09 | 2022-02-08 | キメラポックスウイルス組成物及びその使用 |
| JP2023200433A Active JP7631485B2 (ja) | 2016-08-09 | 2023-11-28 | キメラポックスウイルス組成物及びその使用 |
| JP2025016649A Pending JP2025072482A (ja) | 2016-08-09 | 2025-02-04 | キメラポックスウイルス組成物及びその使用 |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US12084687B2 (https=) |
| EP (1) | EP3497209A4 (https=) |
| JP (4) | JP7023929B2 (https=) |
| KR (3) | KR20230113832A (https=) |
| CN (3) | CN118853594A (https=) |
| AU (2) | AU2017311380A1 (https=) |
| CA (1) | CA3033512A1 (https=) |
| MX (1) | MX2019001672A (https=) |
| RU (2) | RU2757002C2 (https=) |
| WO (1) | WO2018031694A1 (https=) |
Families Citing this family (22)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP4282419A1 (en) | 2012-12-20 | 2023-11-29 | Purdue Research Foundation | Chimeric antigen receptor-expressing t cells as anti-cancer therapeutics |
| CN115300622A (zh) | 2015-02-25 | 2022-11-08 | 纪念斯隆-凯特琳癌症中心 | 使用灭活的修饰的痘苗病毒安卡拉作为实体肿瘤的单一免疫疗法或与免疫检查点阻断剂组合 |
| CN107847534B (zh) | 2015-04-17 | 2022-10-04 | 纪念斯隆凯特琳癌症中心 | Mva或mvaδe3l作为抗实体瘤的免疫治疗剂的应用 |
| KR20180133395A (ko) | 2016-02-25 | 2018-12-14 | 메모리얼 슬로안 케터링 캔서 센터 | 암 면역요법을 위한, 인간 flt3l 또는 gm-csf의 발현이 있거나 없으며 티미딘 키나제가 결실된 복제 가능 약독화 백시니아 바이러스 |
| IL261321B2 (en) | 2016-02-25 | 2023-12-01 | Memorial Sloan Kettering Cancer Center | Recombinant mva or mvadele3l expressing human flt3l and use thereof as immuno-therapeutic agents against solid tumors |
| EP3439675A4 (en) | 2016-04-08 | 2019-12-18 | Purdue Research Foundation | METHOD AND COMPOSITIONS FOR CAR-T CELL THERAPY |
| KR20230113832A (ko) * | 2016-08-09 | 2023-08-01 | 시티 오브 호프 | 키메라 폭스바이러스 조성물 및 이의 용도 |
| WO2018160622A1 (en) | 2017-02-28 | 2018-09-07 | Endocyte, Inc. | Compositions and methods for car t cell therapy |
| WO2018209315A1 (en) | 2017-05-12 | 2018-11-15 | Memorial Sloan Kettering Cancer Center | Vaccinia virus mutants useful for cancer immunotherapy |
| WO2019033030A1 (en) * | 2017-08-11 | 2019-02-14 | City Of Hope | ONCOLYTIC VIRUS EXPRESSING A CAR-T CELL TARGET AND USES THEREOF |
| US11311576B2 (en) | 2018-01-22 | 2022-04-26 | Seattle Children's Hospital | Methods of use for CAR T cells |
| AU2019225174B2 (en) | 2018-02-23 | 2025-11-20 | Endocyte, Inc. | Sequencing method for CAR T cell therapy |
| CA3093093A1 (en) * | 2018-03-07 | 2019-09-12 | Transgene | Parapoxvirus vectors |
| WO2019213173A1 (en) * | 2018-04-30 | 2019-11-07 | City Of Hope | Neural stem cell compositions including chimeric poxviruses for cancer treatment |
| MX2021003013A (es) | 2018-09-15 | 2021-08-11 | Memorial Sloan Kettering Cancer Center | Poxvirus recombinantes para inmunoterapia contra cáncer. |
| CN113583977B (zh) * | 2020-04-30 | 2025-06-06 | 杭州康万达医药科技有限公司 | 可受微小rna调控的分离的重组溶瘤痘病毒及其应用 |
| GB2614309A (en) | 2021-12-24 | 2023-07-05 | Stratosvir Ltd | Improved vaccinia virus vectors |
| WO2023213763A1 (en) * | 2022-05-02 | 2023-11-09 | Transgene | Poxvirus encoding a binding agent comprising an anti- pd-l1 sdab |
| US20260049291A1 (en) | 2022-08-18 | 2026-02-19 | Transgene | Chimeric poxviruses |
| WO2024245722A2 (en) * | 2023-05-26 | 2024-12-05 | Probiogen Ag | Rapid selection system for the generation of recombinant enveloped viruses |
| WO2025184411A1 (en) | 2024-02-27 | 2025-09-04 | Calidi Biotherapeutics (Nevada), Inc. | Serum-resistant eev viruses and uses thereof |
| CN120718864B (zh) * | 2025-08-28 | 2025-11-28 | 山东农业大学 | 一种高度不成熟鸭坦布苏病毒及其培养方法和应用 |
Family Cites Families (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AT406376B (de) | 1998-01-16 | 2000-04-25 | Immuno Ag | Chimäres poxvirus enthaltend eine retrovirale vektorkomponente |
| EP1268763A2 (en) | 2000-03-28 | 2003-01-02 | University Of Rochester | Methods of producing a library and methods of selecting polynucleotides |
| CA2501168A1 (en) * | 2002-11-25 | 2004-06-10 | Bavarian Nordic A/S | Recombinant poxvirus comprising at least two cowpox ati promoters |
| ATE420160T1 (de) * | 2003-06-18 | 2009-01-15 | Genelux Corp | Modifizierte rekombinante vacciniaviren, verwendungen davon |
| EP2097517B1 (en) | 2006-10-16 | 2014-06-04 | Genelux Corporation | Recombinant Lister strain vaccinia virus encoding an anti-VEGF single chain antibody |
| HRP20150360T1 (hr) * | 2007-11-19 | 2015-05-08 | Transgene Sa | Poksvirusni onkolitiäśki vektori |
| US20130071430A1 (en) * | 2010-04-09 | 2013-03-21 | The University Of Tokyo | Microrna-controlled recombinant vaccinia virus and use thereof |
| ES2733211T3 (es) | 2011-04-15 | 2019-11-28 | Genelux Corp | Cepas clonales de virus vaccinia atenuados y métodos de uso de las mismas |
| JP2015520754A (ja) | 2012-05-18 | 2015-07-23 | オタゴ イノベーション リミテッド | 創傷治癒のための組合せ治療および組成物 |
| US10238700B2 (en) | 2014-01-02 | 2019-03-26 | Genelux Corporation | Oncolytic virus adjunct therapy with agents that increase virus infectivity |
| KR20230113832A (ko) * | 2016-08-09 | 2023-08-01 | 시티 오브 호프 | 키메라 폭스바이러스 조성물 및 이의 용도 |
-
2017
- 2017-08-09 KR KR1020237024342A patent/KR20230113832A/ko not_active Ceased
- 2017-08-09 CA CA3033512A patent/CA3033512A1/en active Pending
- 2017-08-09 CN CN202410528631.4A patent/CN118853594A/zh active Pending
- 2017-08-09 EP EP17840232.7A patent/EP3497209A4/en active Pending
- 2017-08-09 JP JP2019507161A patent/JP7023929B2/ja active Active
- 2017-08-09 US US16/324,541 patent/US12084687B2/en active Active
- 2017-08-09 CN CN201780062335.8A patent/CN110199018B/zh active Active
- 2017-08-09 KR KR1020257014373A patent/KR20250067190A/ko active Pending
- 2017-08-09 AU AU2017311380A patent/AU2017311380A1/en not_active Abandoned
- 2017-08-09 CN CN202410528486.XA patent/CN118834840A/zh active Pending
- 2017-08-09 WO PCT/US2017/046163 patent/WO2018031694A1/en not_active Ceased
- 2017-08-09 KR KR1020197006987A patent/KR102557818B1/ko active Active
- 2017-08-09 RU RU2019106319A patent/RU2757002C2/ru active
- 2017-08-09 RU RU2021128158A patent/RU2021128158A/ru unknown
- 2017-08-09 MX MX2019001672A patent/MX2019001672A/es unknown
-
2022
- 2022-02-08 JP JP2022017693A patent/JP7395628B2/ja active Active
-
2023
- 2023-11-20 AU AU2023270200A patent/AU2023270200B2/en active Active
- 2023-11-28 JP JP2023200433A patent/JP7631485B2/ja active Active
-
2024
- 2024-07-17 US US18/776,109 patent/US20250084384A1/en active Pending
-
2025
- 2025-02-04 JP JP2025016649A patent/JP2025072482A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2019524131A5 (https=) | ||
| JP2022065034A5 (https=) | ||
| JP2025072482A5 (https=) | ||
| JP2024026191A5 (https=) | ||
| RU2019106319A (ru) | Композиции химерного поксвируса и их применение | |
| JP2015533841A5 (https=) | ||
| JP2022163182A5 (https=) | ||
| RU2022103603A (ru) | Направляемые нуклеиновыми кислотами нуклеазы | |
| JP2013507935A5 (https=) | ||
| Mizuno et al. | Novel haloarchaeal viruses from Lake Retba infecting Haloferax and Halorubrum species | |
| JP2012509340A5 (https=) | ||
| EA201692359A1 (ru) | Композиция на основе нового штамма prrsv или его белков, продукт, их применение, вирус prrsv, выделенная нк и рекомбинантный вектор экспрессии для получения этого вируса | |
| BR112016020688A2 (pt) | Composições úteis no tratamento da deficiência da ornitina transcarbamilase (otc) | |
| JP2015533297A5 (https=) | ||
| JP2011155981A5 (https=) | ||
| JP2017524348A5 (https=) | ||
| Stik et al. | The oncogenic microRNA OncomiR-21 overexpressed during Marek's disease lymphomagenesis is transactivated by the viral oncoprotein Meq | |
| JP2013523718A5 (https=) | ||
| JP2015533791A5 (https=) | ||
| WO2013030176A3 (en) | Live attenuated influenza virus | |
| JP2019500907A5 (https=) | ||
| MX2024002641A (es) | Uso de micro ácido ribonucleico (arn) para la regulación por disminución de la expresión de transgenes citotóxicos mediante el virus vaccinia ankara modificado (mva). | |
| JP2024535145A5 (https=) | ||
| CN105112412B (zh) | 用于敲除人BTF基因的gRNA序列及其敲除方法 | |
| WO2010009465A3 (en) | Htlv-ii vector and methods of use |